This website is intended for patients that have been prescribed Aspaveli (pegcetacoplan)

ASPAVELI^{® ▼} (pegcetacoplan)

You have been provided with access to this website because your doctor has prescribed Aspaveli for you or someone in your care as a treatment for paroxysmal nocturnal haemoglobinuria (PNH).

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get (see below).

Risk minimisation materials for Aspaveli

You will have received a copy of the below guide and patient card from your doctor or nurse. You should request these if you have not received them. These contain important information and safety considerations for Aspaveli, including the risk of serious infections (including meningitis) and guidance on self administration.

The card should be carried with you at all times during your treatment with Aspaveli and for 12 weeks after your last dose. Show this card to any doctor, nurse or pharmacist who treats you.

Further support materials

The below materials have been developed to provide you with further information and support with your Aspaveli treatment.

Information provided in these materials is not a substitute for the Aspaveli Patient Information Leaflet (PIL) which is provided with your medicine. These materials must be used in conjunction with the Aspaveli Patient Information Leaflet (PIL) which is provided separately. The PIL is also available at https://www.medicines.org.uk/emc/product/13369/pil. The information provided in this leaflet does not take the place of professional medical advice. Always follow your doctor, nurse or pharmacist´s instructions and talk with them about any questions or problems you have regarding your health and treatment.

Reporting of side effects

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. You can report side effects by contacting your doctor, nurse or pharmacist or you can report side effects directly via the Yellow Card scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store.

Job code: NP-26054 Date of preparation: February 2023